Medicus Pharma Ltd. Common Stock (MDCX)

Medicus Pharma Ltd. Common Stock (MDCX) is a Drug Manufacturers - General company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3.8M; returns 1 day -4.6%, 1 week -23.1%, 1 year -97.9%.

Medicus Pharma Ltd. (MDCX) is a diversified clinical-stage biotechnology company primarily focused on the development of non-invasive oncology and urology therapeutics. As of June 2026, the company operates two core clinical platforms: SkinJect and Teverelix.

Groups MDCX belongs to

• Recent Reverse Splits
• Clinical Stage
• Biotechnology
• Healthcare
• Clinical Stage Biotech
• Oncology
• Pharmaceuticals
• Cancer Therapeutics
• Dermatology

MDCX financial model: income statement, cash flow and balance sheet